CoaguSafe

These are the main features. See below for further details

NOTE CoaguSafe is not a substitute for medical advice. CoaguSafe is intended for educational purposes only.

Medication

listed by generic or brand name.

Drug groups

Mode of action, monitoring and antagonism.

Pausing

Suspension before invasive procedures.

iphone

Bridging

thromboembolic risk and need of briding.

Cardiovascular risk

Estimate cardiovascular and surgical bleeding risk.

Guidelines

international, national and also local guidelines.

CoaguSafe

the app solution for management of invasive procedures in patients with antithrombotic agents

NOTE CoaguSafe is not a substitute for medical advice. CoaguSafe is intended for educational purposes only.

iphones skew

When to pause an antithrombotic agent ?

CoaguSafe has a list of most antithrombotic agents. These can be sorted by generic or brand name. Recommendations for pausing (according to international guidelines) are already visible in list view. The detail view expands on high- or low-risk procedures and - if appropriate - on patients with renal insufficency.

Each drug belongs to a drug class, i.e. thrombin inhibitors, FXa inhibitors, glycoproteine IIbIIIa inhibitors and others. Mode of action and monitoring is described for each group.

For iPhone and iPad

On warfarin or new oral anticoagulant ?

Oral anticoagulation has to be suspended for many invasive procedures. These patients might need 'bridging' with low molecular weight heparin (LMWH), dependent on the thromboembolic risk.

The thromboembolic profile is dependent on:

  • Valvular risk factors
  • Atrial fibrillation and CHADS2 VA2Sc score
  • Probability of venous thromboembolism

Management of the new oral anticoagulants (NOAC) is frequently dependent on renal function. Therefore renal function is also accounted for.

iphones two
iphones two

Cardiovascular and bleeding risk?

Pausing antithrombotic drugs is important before invasive procedures are performed. On the other hand there are situations in which such suspension of antithrombotic agents might not be recommended.

The cardiovascular risk (e.g. recent coronary stents - bare metal or drug-eluting) as well as bleeding risk of the invasive procedure can be estimated.

Based on these two estimations suggestions of the guidelines are presented.

Guidelines

CoaguSafe is based on international and national guidelines. After selection of a guideline the respective recommendations are presented. If a specific drug is not included in the selected guideline, then alternative recommendations are shown (and labelled with an asterix).

The following guidelines are currently included:

  • American society of regional anesthesia and pain therapy (ASRA)
  • Deutsche Gesellschaft für Anästhesie und Intensivmedizin (DGAI)
  • European society of anaesthesiology (ESA)
  • Kantonsspital St. Gallen
  • United Kingdom (AAGBI, OAA, RA-UK)
  • Österreichische Gesellschaft Anästhesiologie, Reanimation und Intensivmedizin (ÖGARI)

Should a particular guideline be missing, then drop me an email. On specific request local guidelines can also be included.

iphones two

Reviews

Beurteilungen aus dem AppStore

client

Für den klinischen Alltag

2. Oktober 2016

"Wer kann sich schon alles merken? Diese ausgezeichnete Gedächtnisstütze ist genau das, was man im klinischen Alltag braucht, wenn man nicht mehr alles im Kopf hat. Hab es schon mehrfach weiter empfohlen!!"

client

Super!

26. September 2016

"Extrem praktisch. Verschiedene Guidelines berücksichtigt. Wirklich sehr gut für unseren Alltag geeignet!"

client

Super

24. August 2016

"Bequem, übersichtlich, einsame Spitze!"

client

Eine unschätzbare Hilfe...

7. Oktober 2015

"...die ein kompliziertes, für den klinisch tätigen Anästhesisten zunehmend wichtiges Thema kompetent, umfassend, übersichtlich und aktuell darstellt. Genial: Hinterlegung verschiedener internationaler Leitlinien zur Auswahl. Ich benutze die App häufig und kenne nichts annähernd vergleichbares!"